Bank of Montreal
KDNY

Bank of Montreal’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bank of Montreal’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-347
Closed -$5K – 5229
2021
Q1 		$5K Sell
347
-1,684
-83% -$27.5K ﹤0.01% 4677
2020
Q4 		$33K Buy
2,031
+1,415
+230% +$21.3K ﹤0.01% 4174
2020
Q3 		$45K Sell
616
-448
-42% -$6K ﹤0.01% 3487
2020
Q2 		$14K Buy
+1,064
New +$14.7K ﹤0.01% 4025
2020
Q1 		– Sell
-1,720
Closed -$10K – 4883
2019
Q4 		$10K Buy
1,720
+571
+50% +$3.1K ﹤0.01% 4580
2019
Q3 		$6K Buy
1,149
+40
+4% +$266 ﹤0.01% 4538
2019
Q2 		$9K Buy
1,109
+798
+257% +$12.2K ﹤0.01% 4574
2019
Q1 		$6K Buy
311
+130
+72% +$2.27K ﹤0.01% 4008
2018
Q4 		$2K Buy
181
+92
+103% +$1.84K ﹤0.01% 4445
2018
Q3 		$3K Sell
89
-101
-53% -$3.24K ﹤0.01% 4278
2018
Q2 		$6K Buy
190
+91
+92% +$3.49K ﹤0.01% 4101
2018
Q1 		$5K Sell
99
-7
-7% -$256 ﹤0.01% 3923
2017
Q4 		$4K Sell
106
-74
-41% -$3.23K ﹤0.01% 3974
2017
Q3 		$10K Sell
180
-51
-22% -$3.03K ﹤0.01% 3712
2017
Q2 		$13K Buy
231
+77
+50% +$3.87K ﹤0.01% 3667
2017
Q1 		$8K Sell
154
-101
-40% -$5.71K ﹤0.01% 3624
2016
Q4 		$15K Sell
255
-19
-7% -$1.15K ﹤0.01% 3481
2016
Q3 		$17K Buy
274
+138
+101% +$9.76K ﹤0.01% 3413
2016
Q2 		$8K Sell
136
-1,604
-92% -$97.5K ﹤0.01% 3638
2016
Q1 		$111K Buy
+1,740
New +$141K ﹤0.01% 2757

Other funds holding KDNY

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of Montreal's KDNY Position: Q2 2021 in Review

Bank of Montreal sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q2 2021, closing a stake of 347 shares — an estimated $5K sold.

Bank of Montreal first reported a position in KDNY in Q1 2016 and held it in 20 quarters. The position peaked at $111K in Q1 2016. 89 funds tracked by Wall St. Rank hold KDNY as of Q2 2021.

  • Bank of Montreal reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 347 Chinook Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $5K.
  • Bank of Montreal first reported a position in Chinook Therapeutics, Inc. Common Stock in Q1 2016 and held it in 20 quarters.
  • Bank of Montreal's Chinook Therapeutics, Inc. Common Stock position peaked at $111K in Q1 2016.
  • 89 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.